Anteo Diagnostics Blog

Funding For New Rapid Blood Test To Help Detect Heart Attacks: Atomo Partners with Anteo

Anteo is pleased to announce that it will partner with Sydney-based Atomo Diagnostics to develop a clinical prototype of a cost effective and accurate point of care test for the

Continue
Video: Mix&Go™ Could Solve Clinical Sample Interference

The lecture our VP of Scientific Affairs, Josh Soldo gave at AACC 2015 is now available. Lecture summary Interference is a substance present in a patient specimen that can alter

Continue
Anteo Diagnostics 2015 Annual Report Available Now

The Anteo Diagnostics 2015 Annual Report is now available and includes: Chairman’s Report CEO’s Report Operating and Financial Review Report Statutory Reports DOWNLOAD THE ANTEO DIAGNOSTICS 2015 ANNUAL REPORT HERE

Continue
Anteo Diagnostics to Acquire Established Global Diagnostics Company DIAsource ImmunoAssays SA

26 August 2015 – The Board of Directors of Anteo Diagnostics (ASX: ADO) (Anteo) is pleased to announce that it will acquire DIAsource ImmunoAssays, SA (DIAsource), an established global specialty

Continue
CEO Activities Report – Quarter Ended 30 June 2015

The Company has been extremely busy in the period since our last report. This CEO Activities Report provides context and further information on the highlights of last quarter. In summary:

Continue
AACC Conference Summary and CEO Interview

Anteo Diagnostics Limited (ASX:ADO) (“Anteo” or the “Company”), released a copy of the presentation that Joshua Soldo delivered to a full house at the AACC OEM Lecture Series on Tuesday

Continue
Gearing Up For AACC: Anteo Extends Relationship with Sigma-Aldrich

Leading up to AACC, Anteo announced the distribution of their Mix&Go™ product range through Sigma-Aldrich. Mix&Go Reagents, Coupling and Activation Kits are expected to be available during Q3 of CY2015.

Continue
SCIENION and Anteo Partner to Develop Consumables for Better Functionality and Longer Shelf Life of Protein Microarrays

SCIENION, a leading global provider of ultra-low volume precision liquid handling systems, and Australian biotech company Anteo Technologies today announced that they have partnered to co-develop protein microarray consumables using

Continue
Van Leeuwenhoeck Research: Anteo Diagnostics – Emerging Leader in Nanotechnology

On July 13 2015, Van Leeuwenhoeck released their Research Note about Anteo Diagnostics. The highlights include: In the IVD market, Anteo is successfully implementing a strategy that has the ability

Continue
Josh Soldo, VP Scientific Affairs Presents at Beckman Coulter’s Knowledge Café

By invitation from Beckman Coulter, Anteo’s VP of Scientific Affairs, Josh Soldo, presented at their Knowledge Café on Wednesday 8 July to a great reception. Beckman’s Knowledge Café is an

Continue
Anteo Begins InVivo Research Partnership with UQ

Today Anteo Technologies Pty Ltd (a subsidiary of Anteo Diagnostics Limited, ASX: ADO) is pleased to announce the launch of a research partnership with the Australian Institute for Bioengineering and

Continue
Luminex® Shows Support for Anteo Mix&Go™ Activation Kit for Multiplex Microspheres

We are excited to announce that Luminex have shown their support for the Anteo Mix&Go (AMG) Activation Kit for Multiplex Microspheres via a blog post. This AMG Activation Kit has

Continue